TARS
#1869
Tarsus Pharmaceuticals, Inc. - Common Stock
56.7 7 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.18%
Monthly Change
-8.63%
6 month change
-22.88%
Year Change
-14.06%
Previous Close
56.1 1
Open
55.5 5
Low
55.5 5
High
56.7 7
Volume
615
Financials
- Market Capitalization 2.44 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-63.2
Price to sales ratio
5.56
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1850 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.81 USD | -0.56% | -3.31% | +21.40% | +159.62% | 2.53 B USD | ||
| 1867 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.74 USD | +3.31% | -0.50% | +40.22% | +111.78% | 2.46 B USD | ||
| 1871 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.08 USD | -2.32% | +6.78% | +72.11% | +581.25% | 2.43 B USD | ||
| 1875 |  VCEL Vericel Corporation - Common Stock | 47.23 USD | +2.47% | +0.79% | +22.93% | +29.93% | 2.41 B USD |
Frequently asked questions about Tarsus Pharmaceuticals, Inc. - Common Stock
What is the Tarsus Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) is 56.77. Over the past 24 hours, the stock has changed by +1.18%. Follow the TARS chart for real-time price dynamics.
What is the stock ticker of Tarsus Pharmaceuticals, Inc. - Common Stock?
Tarsus Pharmaceuticals, Inc. - Common Stock trades under the ticker TARS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Tarsus Pharmaceuticals, Inc. - Common Stock stock going up?
TARS has changed by -18.16% over the last week, -8.63% over the last month, and -14.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Tarsus Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Tarsus Pharmaceuticals, Inc. - Common Stock reported net income of -6.97 M for the last quarter. The previous quarter showed -8.37 M, which means net income changed by +16.79%.
How many employees does Tarsus Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Tarsus Pharmaceuticals, Inc. - Common Stock has 370 employees. Workforce size can provide additional context about the company's scale and operations.
What is Tarsus Pharmaceuticals, Inc. - Common Stock EBITDA?
Tarsus Pharmaceuticals, Inc. - Common Stock EBITDA is -6.38 M, and its EBITDA margin is -3.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Tarsus Pharmaceuticals, Inc. - Common Stock stock?
You can buy Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Tarsus Pharmaceuticals, Inc. - Common Stock stock?
Investing in Tarsus Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARS chart and related analysis on metatrader.com as part of your research.